Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
64
天
Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer
作者
I-SPY2 Trial Investigators and Advocates; Ciara C. O’Sullivan; Kevin M. Kalinsky; Christina Yau; Tejaswini Kulkarni; Douglas Yee; Anne M. Wallace; A. Jo Chien; Judy C. Boughey; Anthony D. Elias; Rita Nanda; Claudine Isaacs; Coral Omene; Erica Stringer-Reasor; Amy S. Clark; Alexandra Thomas; Heather S. Han; Nancy Chan; Nicole Williams; Meghna S. Trivedi; Mili Arora; Christos Vaklavas; Jennifer Tseng; Satya Bommakanti; Jesus D. Anampa Mesias; Alexandra Zimmer; Carla Falkson; Evanthia Roussos Torres; Chaitali Nangia; Kathy S. Albain; Mariya Rozenblit; Somaye Zare; Soudabeth Fazelli; Yunni-Yi Chen; Laura A. Huppert; An L. Church; Heather Beckwith; Evelyn Carroll; Malvika Solanki; Virginia F. Borges; Sarah E. A. Tevis; Nan Chen; Jay C. Zeck; Maria J. Kowzun; Jessica Sullivan; Natalie Marshall; Molly E. Klein; Karthik V. Giridhar; Radhika Acharya-Leon; Betty Fan; Elaine M. Walsh; Anya Litvak; Nusrat Jahan; Elizabeth McDonald; Emily Hughes Douglas; Jameel Zena; Amber Guth; Kai Johnson; Julia E. McGuinness; Kant Matsuda; Shadi Shakeri; Jairam Krishnamurthy; Irene Kang; Abigail Madans; Sheldon Feldman; Monica Johnson; Hani Katerji; Yangling Ma; Jeffrey B. Matthews; Amy L. Delson; Barbara LeStage; Jane Perlmutter; Emanuel F. Petricoin; Rebecca A. Shatsky; Elissa Price; Amrita Basu; Adam L. Asare; Teresa Helsten; Marisa Howard McNatt; Rita A. Mukhtar; W. Fraser Symmans; Alexander D. Borowsky; Dawn L. Heshman; Angela M. DeMichele; Hope S. Rugo; Nola M. Hylton; Laura J. van ’t Veer; Laura J. Esserman展开收起
作者单位
1. Mayo Clinic, Rochester, Minnesota; 2. Emory University Winship Cancer Institute, Atlanta, Georgia; 3. University of California, San Francisco; 4. University of Alabama, Birmingham; 5. University of Minnesota, Minneapolis; 6. University of California, San Diego, La Jolla; 7. University of Colorado, Aurora; 8. University of Chicago, Chicago, Illinois; 9. Georgetown University, Washington, DC; 10. Rutgers Cancer Institute of New Jersey, New Brunswick; 11. Cooperman Barnabas Medical Center, Livingston, New Jersey; 12. University of Pennsylvania, Philadelphia; 13. Wake Forest, Winston-Salem, North Carolina; 14. Duke University, Durham, North Carolina; 15. Moffitt Cancer Center, Tampa, Florida; 16. New York University, New York; 17. The Ohio State University, Columbus; 18. Columbia University, New York, New York; 19. UC Davis Health, Sacramento, California; 20. University of Utah Huntsman Cancer Institute, Salt Lake City; 21. City of Hope (Lennar), Duarte, California; 22. Health Partners Institute–Hennepin, Minneapolis, Minnesota; 23. Montefiore Medical Center, New York, New York; 24. Oregon Health and Science University, Portland; 25. University of Rochester Medical Center, Rochester, New York; 26. University of Southern California, Los Angeles; 27. Hoag Family Cancer Institute, Irvine, California; 28. Loyola University Medical Center, Maywood, Illinois; 29. Yale University, New Haven, Connecticut; 30. I-SPY2 Patient Advocates, University of California, San Francisco; 31. Gemini Group, Ann Arbor, Michigan; 32. George Mason University, Fairfax, Virginia; 33. Quantum Leap Healthcare Collaborative, San Francisco, California; 34. MD Anderson, Houston, Texas; 35. City of Hope, Duarte, California展开收起
10
天
42
天
Trends in Meningioma Incidence, Treatment, and Imaging Surveillance
作者
Anders Rosendal Korshøj; Henriette Engberg; Mette Haldrup; Anne Kudsk Ragner; Brian Lind Olsen; Khuozima Azam; Tiit Illimar Mathiesen; Mahmoud Albarazi; David Scheie; Slavka Lukacova; Kåre Schmidt Ettrup; Christian Bonde Pedersen; Jane Skjøth-Rasmussen; Steinbjørn Hansen展开收起
作者单位
1. Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark; 2. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 3. The Danish Healthcare Quality Institute, Odense, Denmark; 4. Department of Neurosurgery, Odense University Hospital, Odense, Denmark; 5. Department of Neurosurgery, Rigshospitalet, København, Denmark; 6. Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark; 7. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 8. Department of Pathology, Rigshospitalet, København, Denmark; 9. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; 10. Department of Neurosurgery, Aalborg University Hospital, Gistrup, Denmark; 11. Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 12. Department of Oncology, Odense University Hospital, Odense, Denmark展开收起
148
天
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer
作者
Maria M. Karsten; Pimrapat Gebert; Therese Pross; Anna M. Hage; Adam D. Dordevic; Susan Stephan; Friedrich Kühn; Lea Doppelbauer; Jens-Uwe Blohmer; Felix Fischer; Matthias Rose; Anna Pöhlmann; Bianca Materne; Morten Aagaard Petersen; Luis Pauler; Julia Ferencz; Simone Wesselmann; Clara Breidenbach; Ulrike Grittner; Christoph Kowalski展开收起
作者单位
1. Department of Gynecology with Breast Center, Charité–Universitätsmedizin Berlin, Berlin, Germany; 2. Berlin Institute of Health at Charité– Universitätsmedizin Berlin, Berlin, Germany; 3. Institute of Biometry and Clinical Epidemiology, Charité–Universitätsmedizin Berlin, Berlin, Germany; 4. Department of Psychosomatic Medicine and Psychotherapy, Theodor-Wenzel-Werk e.V., Berlin, Germany; 5. Center for Patient-Centered Outcomes Research, Department for Psychosomatic Medicine, Charité–Universitätsmedizin Berlin, Berlin, Germany; 6. Palliative Care Research Unit, Department of Geriatrics and Palliative Medicine GP, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; 7. OnkoZert, Neu-Ulm, Germany; 8. Deutsche Gesellschaft für Allgemein und Viszeralchirurgie e.V., Berlin, Germany; 9. German Cancer Society, Berlin, Germany展开收起
148
天
Mathematical Biomarkers of Adaptive Therapy Outcomes in Prostate Cancer
作者
Kit Gallagher; Maximilian A. Strobl; Robert A. Gatenby; Jingsong Zhang; Philip K. Maini; Alexander R. Anderson展开收起
作者单位
1. Wolfson Centre for Mathematical Biology, Mathematical Institute, Oxford, United Kingdom; 2. Integrated Mathematical Oncology Department, Moffitt Cancer Center, Tampa, Florida; 3. Theory Division, Cleveland Clinic, Cleveland, Ohio; 4. Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom; 5. Department of Life Sciences, Imperial College London, London, United Kingdom; 6. Department of Radiology, Moffitt Cancer Center, Tampa, Florida; 7. Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天